BioPharma Media

BioPharma Media BioPharma Media tells you what others are not telling you.

BioPharma Media is a specialized analytical service engaged in scientific research, reference, and information activities by targeting key events in the global pharmaceutical, biotechnology, medical, and healthcare industries.

→   ( ) is a game-changer in the world of weight loss.→ Ozempic is flying off the shelves. Novo Nordisk is struggling to...
05/03/2024

→ ( ) is a game-changer in the world of weight loss.
→ Ozempic is flying off the shelves. Novo Nordisk is struggling to keep up with demand, with virtual queues forming at drugstores.
→ Originally, Ozempic was meant to treat type 2 diabetes ( ). But word of mouth on social media has been its biggest marketing tool. Now, people with obesity or overweight issues are using it.
→ People are going crazy over it. Ozempic’s high efficacy has led to millions losing significant weight.
→ The results are pretty impressive: dozens of pounds of fat, the burden of associated overweight diseases, depression, anxiety, and self-disgust — all gone!



What can you expect from Ozempic, a miracle drug for weight loss and more? Will your physical appearance change a lot? Will you feel more confident?

→ High blood pressure affects 1.3 billion people globally.→ Current   medications may not be effective in the long term....
04/27/2024

→ High blood pressure affects 1.3 billion people globally.
→ Current medications may not be effective in the long term.
→ Completely new approach involves blocking production in liver.
→ New drugs can be administered monthly, quarterly, or even semi-annually.
→ and — fast, reliable, expensive!



Zilebesiran and tonlamarsen are advanced and convenient ways to treat high blood pressure.

→   (herpes zoster) is a common disease that causes a rash and pain.→ The risk of encountering shingles increases dramat...
04/24/2024

→ (herpes zoster) is a common disease that causes a rash and pain.
→ The risk of encountering shingles increases dramatically with age.
→ (RZV) by is the only vaccine that provides unequivocally powerful and reliable protection against shingles.
→ Once vaccinated with Shingrix, immunity against shingles lasts for 10 years or even longer.
→ The pharmaceutical industry continues to look for options to improve the protective performance of Shingrix.



Shingrix for robust and long-lasting prevention of herpes zoster and postherpetic neuralgia in all adults.

* Low-grade   ( ) is the most prevalent central nervous system tumor in children.* Surgical resection is a reliable meth...
04/24/2024

* Low-grade ( ) is the most prevalent central nervous system tumor in children.

* Surgical resection is a reliable method for achieving complete remission of LGG.

* However, surgical intervention is not an appropriate treatment option for all patients with LGG, necessitating the use of a prolonged course of chronic therapy that is burdensome, exhausting, and toxic.

* ( ) is a novel drug that is anticipated to become the standard of care for first-line pharmacologic treatment of LGG.

* The administration of tovorafenib results in a rapid reduction in tumor size and is well tolerated.



Tovorafenib represents a novel standard of care for the most prevalent central nervous system neoplasm affecting children.

* Personalized cancer vaccines are the future of cancer treatment.* These vaccines are tailored to the tumor specificity...
04/15/2024

* Personalized cancer vaccines are the future of cancer treatment.
* These vaccines are tailored to the tumor specificity of each patient and can be manufactured quickly.
* The first individualized oncovaccine adhering to the concept of precision medicine will be available in 2025.
* Successful treatment of melanoma and head and neck cancer has already been demonstrated.
* Lung, kidney, bladder and non-melanoma skin cancers are next in line.





mRNA technologies paint an optimistic future in cancer treatment.

* Pancreatic cancer is a highly challenging oncologic disease to treat.* Only 20% of patients are eligible for surgical ...
04/15/2024

* Pancreatic cancer is a highly challenging oncologic disease to treat.
* Only 20% of patients are eligible for surgical tumor resection.
* Even if tumors are successfully removed, they almost always recur, leading to rapid death.
* A personalized cancer vaccine, autogene cevumeran by and of , has been shown to delay recurrence and death by three years in one-third of patients.
* However, the availability and cost of this breakthrough therapy remain open questions.





Personalized immunotherapy prolonged life in one-third of patients with pancreatic ductal adenocarcinoma.

* Liver cancer still remains a highly deadly disease.* All existing drugs only provide marginal life extension for unres...
04/15/2024

* Liver cancer still remains a highly deadly disease.
* All existing drugs only provide marginal life extension for unresectable liver cancer.
* A personalized cancer vaccine, GT-30 by Therapeutics, offers the potential for complete remission or cure.
* However, this treatment is customized for each patient.
* The cost of such treatment is also a significant consideration.





Geneos Therapeutics has figured out how to cure unresectable hepatocellular carcinoma.

  ( ) effectively prevents   in those who cannot be vaccinated. Nexsheld is   and updated version of   that takes into a...
04/01/2024

( ) effectively prevents in those who cannot be vaccinated. Nexsheld is and updated version of that takes into account new variants.



Sipavibart injection every six months for reliable prevention of COVID-19.

  by   Pharma is a nice addition to the existing armamentarium of hypotensive drugs, which has not been updated for many...
11/29/2022

by Pharma is a nice addition to the existing armamentarium of hypotensive drugs, which has not been updated for many years.

Adding baxdrostat to the usual cardiology drugs solves the problem of high blood pressure in resistant or uncontrolled .



A selective aldosterone synthase inhibitor for significantly lowering blood pressure.

Japan’s   & Co. has offered   ( ), a new drug for treating   infection caused by the   coronavirus.Xocova works just lik...
11/29/2022

Japan’s & Co. has offered ( ), a new drug for treating infection caused by the coronavirus.

Xocova works just like the extremely popular ( + ) from by suppressing viral replication.

While Paxlovid needs to be taken twice a day, Xocova only once.
In addition, the Japanese is free of the problem of drug interaction: Treatment with Paxlovid in some cases requires temporary cessation of taking other medicines.

And perhaps most importantly, Xocova is allowed to treat patients regardless of the presence of risk factors for progression of the infection to a severe form.



Ensitrelvir by Shionogi & Co. is a highly effective antiviral drug that works just as well as Pfizer’s Paxlovid.

  /   (sodium   +  ) is a new drug indicated for the treatment of amyotrophic lateral sclerosis ( ).The mechanism of act...
09/30/2022

/ (sodium + ) is a new drug indicated for the treatment of amyotrophic lateral sclerosis ( ).

The mechanism of action of Relyvrio/Albrioza, developed by Pharmaceuticals, aims to inhibit the dysfunction and death of motor neurons.

Relyvrio/Albrioza reduces the risk of death by 44%. Considering that the median survival rate for ALS is approximately 4 years from symptom onset, continued administration of Relyvrio/Albrioza can extend life to 6–6.5 years.

Relyvrio is approved in the US and Albrioza is approved in Canada.

The cost of Relyvrio/Albrioza for ALS treatment is high, and therefore the drug seems to be available to patients only in countries with developed health insurance.



Amylyx Pharmaceuticals proposed mixture of sodium phenylbutyrate and tauroursodeoxycholic acid for ALS treatment.

  (elivaldogene autotemcel) is a gene therapy indicated to treat cerebral adrenoleukodystrophy ( ).Skysona, developed by...
09/19/2022

(elivaldogene autotemcel) is a gene therapy indicated to treat cerebral adrenoleukodystrophy ( ).

Skysona, developed by , is used once.

The cost of Skysona in the United States is set at $3 million.



A single dose of the elivaldogene autotemcel will cure a deadly disease.

Address

200 Piedmont Avenue SE
East Atlanta, GA
30334

Alerts

Be the first to know and let us send you an email when BioPharma Media posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram